Accordingly, by collecting relevant literature data and conducting a meta-analysis, we can gain a more comprehensive understanding to verify whether Klotho is a feasible biomarker for the diagnosis and prediction of CKD–MBD progression. This evidence concerns the gene KL and chronic kidney disease.